ロード中...
Proton Pump Inhibitor Prescribing Patterns in Newborns and Infants
OBJECTIVES: In 2011, the Food and Drug Administration (FDA) approved intravenous esomeprazole 0.5 mg/day for children aged >1 month and oral esomeprazole for infants aged 1 month to <1 year at doses of 2.5, 5, and 10 mg based on weight. Prior to 2011, proton pump inhibitors (PPIs) were not app...
保存先:
| 出版年: | J Pediatr Pharmacol Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pediatric Pharmacy Advocacy Group
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341413/ https://ncbi.nlm.nih.gov/pubmed/25762873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-19.4.283 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|